Want to see AU:4DX full AI Analyst Report?
Total Valuation
4DMedical Ltd has a market cap or net worth of AU$2.59B. The enterprise value is AU$2.43K.
Market CapAU$2.59B
Enterprise ValueAU$2.43K
Share Statistics
4DMedical Ltd has 601,591,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding601,591,060
Owned by Insiders12.15%
Owned by Institutions―
Financial Efficiency
4DMedical Ltd’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is -15.65%.
Return on Equity (ROE)-1.20
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-15.65%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee56.95K
Profits Per Employee-1.65M
Employee Count124
Asset Turnover0.02
Inventory Turnover208.18
Valuation Ratios
The current PE Ratio of 4DMedical Ltd is ―. 4DMedical Ltd’s PEG ratio is 1.92.
PE Ratio―
PS Ratio4371.54
PB Ratio181.41
Price to Fair Value181.41
Price to FCF-957.95
Price to Operating Cash Flow-82.32
PEG Ratio1.92
Income Statement
In the last 12 months, 4DMedical Ltd had revenue of 7.06M and earned -204.44M in profits. Earnings per share was -0.03.
Revenue7.06M
Gross Profit-38.08M
Operating Income-57.46M
Pretax Income-210.23M
Net Income-204.44M
EBITDA-52.00M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -31.27M and capital expenditures -949.83K, giving a free cash flow of -32.22M billion.
Operating Cash Flow-31.27M
Free Cash Flow-32.22M
Free Cash Flow per Share-0.05
Dividends & Yields
4DMedical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.59
52-Week Price Change183.55%
50-Day Moving Average3.70
200-Day Moving Average4.01
Relative Strength Index (RSI)63.86
Average Volume (3m)4.00M
Important Dates
4DMedical Ltd upcoming earnings date is Feb 26, 2027, Before Open (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateFeb 26, 2027
Ex-Dividend Date―
Financial Position
4DMedical Ltd as a current ratio of 30.79, with Debt / Equity ratio of 1.89%
Current Ratio30.79
Quick Ratio30.77
Debt to Market Cap<0.01
Net Debt to EBITDA5.28
Interest Coverage Ratio-21.08
Taxes
In the past 12 months, 4DMedical Ltd has paid -5.80M in taxes.
Income Tax-5.80M
Effective Tax Rate0.03
Enterprise Valuation
4DMedical Ltd EV to EBITDA ratio is -588.35, with an EV/FCF ratio of -949.43.
EV to Sales4.33K
EV to EBITDA-588.35
EV to Free Cash Flow-949.43
EV to Operating Cash Flow-978.26
Balance Sheet
4DMedical Ltd has AU$277.95M in cash and marketable securities with AU$3.22M in debt, giving a net cash position of AU$274.74M billion.
Cash & Marketable SecuritiesAU$277.95M
Total DebtAU$3.22M
Net CashAU$274.74M
Net Cash Per ShareAU$0.46
Tangible Book Value Per ShareAU$0.01
Margins
Gross margin is -539.23%, with operating margin of -813.68%, and net profit margin of -2895.06%.
Gross Margin-539.23%
Operating Margin-813.68%
Pretax Margin-2977.16%
Net Profit Margin-2895.06%
EBITDA Margin-736.40%
EBIT Margin-813.68%
Analyst Forecast
The average price target for 4DMedical Ltd is AU$5.05, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$5.05
Price Target Upside30.15% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast20.64%
EPS Growth Forecast-457.40%